A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

REFERENCES

• Borner MM, Schöffski P, de Wit R, et al. Patient preference and pharmacokinetics of oral modulated UFT versus intrave-nous fluorouracil and Leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 2002; 38: 349–58.
   PubMed Web of Science ®Google Scholar
• Pazdur R, Douilard J-Y, Sillings JR, et al. Multicenter phase II study of 5-fluorouracil (5-fluorouracil) or UFT in combination with Leucovorin (LV) in patients with metastatic colorectal cancer. ASCO 1999; 18: Abstract 1009.
   Google Scholar
• Carmichael J, Popiela T, Radstone D, et al. Randomized comparative study of ORZEL (oral uracil tegafur (UFT)) plus Leucovorin (LV) versus parenteral 5-fluorouracil (5-fluorouracil) plus LV in patients with metastatic colorectal cancer. ASCO 1999; 18: Abstract 1015.
   Google Scholar
• Hill M, Mackay H, Cunningham D, et al. Phase I/II study of oral uracil/tegafur (UFT'®) Leucovorin and irinotecan in patients with advanced colorectal cancer. Ann Oncol 2002; 11 (suppl. 4): Abstract 193P.
   Google Scholar
• Javier Dorta F, Feliu J, Vincent J, et al. Phase II clinical trial with the combination of oxaliplatin-UFT-1,-Leucovorin (OXA-UFT-1,LV) for the first line treatment of advanced colorectal cancer (ACC). Preliminary results (Oncopaz Cooperative Group-Spain). Ann Oncol 2002; 11\(Suppl. 4): Abstract 220P.
   Google Scholar
• Jakobsen A, Pfeiffer P, Hansen F, et al. dual modulation of UFT with Leucovorin and hydroxurea in metastatic colorectal cancer. Acta Oncologica 2001; 40: 63–6.
   PubMedGoogle Scholar
• Moore GE, Bross ID, Ausman R, et al. Effects of mitomycin C (NSC-26980) in 346 patients with advanced cancer. Cancer Chemother Rep 1968; 52: 675–84.
   PubMedGoogle Scholar
• Moertel C, Reitmeier R, Hahn R. Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 1968; 204: 1045–8.
   Google Scholar
• Rusello O, Romanini A, Civalleri D, et al. Time-dependent interactions between 5-fluorouracil and mitomycin C on a human colon cancer cell line, HCT-8, in vitro. EUR J Cancer Clin Oncol 1989; 25: 571–2.
   Google Scholar
• Krauss S, Sonoda T, Solomon A. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C. Cancer 1979; 43: 1598–603.
   Google Scholar
• Richards F, Case LD, White DR, et al. Combination che-motherapy (5-fluorouracil, methyl-CCNU, mitomycin C) ver-sus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont OncologyAssociation. J Clin Oncol 1986; 4: 565–70.
   PubMed Web of Science ®Google Scholar
• Ross P, Norman A, Cunningham D, et al. A prospective randomized trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol 1997; 8: 995–1001.
   PubMed Web of Science ®Google Scholar
• Epidermoid Anal Cancer: Results from the UKCCCR Rando-mised Trial of Radiotherapy Alone Versus Radiotherapy, 5-Fluorouracil, and mitomycin. Lancet. 1996; 348: 1049–54.
   PubMedGoogle Scholar
• Chan AK, Wong AO, Langevin J, et al. Preoperative che-motherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000; 48: 843–56.
   PubMed Web of Science ®Google Scholar
• Herrmann R. 5-fluorouracil and mitomycin C in colorectal cancer: unacceptable conclusion. Ann Oncol 1998; 9(2): 230.
   PubMedGoogle Scholar
• Meta-analysis Group in Cancer. Efficacy of intravenous con-tinuous infusion of fluorouracil compared with bolus admin-istration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301–8.
   PubMed Web of Science ®Google Scholar
• Ikeda E, Kodaira S, Teramoto T, et al. Optimal dosage of UFT+MMC combination chemotherapy for advanced color-ectal cancer-phase 1/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT admin-istration-Study Group of UFTM Therapy for Advanced colorectal cancer. Gan To Kagaku Ryoho 1998; 23: 1291–8.
   Google Scholar